Fosamax Mar 5

Client Attorney Privileged/Attorney Work Product/At Request of Counsel

1. New Guidance to Prevent Bisphosphonate-Related Atypical Femoral Fractures

   Mar 4, 2015 | News Medical

   Physicians worldwide frequently prescribe bisphosphonates such as alendronate (Fosamax) and ibandronate (Boniva) to treat osteoporosis and prevent fragility fractures. Unfortunately, long-term bisphosphonate use has been linked to an increased risk of atypical femoral fractures.

Full Text of Stories Below

Client Attorney Privileged/Attorney Work Product/At Request of Counsel

1. New Guidance to Prevent Bisphosphonate-Related Atypical Femoral Fractures

   Mar 4, 2015 | News Medical

   Physicians worldwide frequently prescribe bisphosphonates such as alendronate (Fosamax) and ibandronate (Boniva) to treat osteoporosis and prevent fragility fractures. Unfortunately, long-term bisphosphonate use has been linked to an increased risk of atypical femoral fractures. In the March 3, 2015 edition of JBJS Reviews, Blood et al. offer some guidance on how to prevent such fractures.

   The authors note that prodromal thigh pain and a radiolucent line on X-rays of patients with a history of chronic bisphosphonate use are strong indicators of an impending fracture. Among bisphosphonate users who have an incomplete fracture with little or no pain, the authors recommend a trial of bisphosphonate discontinuation, protected weight-bearing, calcium and vitamin-D supplementation, and possible teriparatide (Forteo) therapy. They add that prophylactic fixation should be considered if there is no radiographic or symptomatic improvement after two to three months of that conservative approach. Blood et al. further recommend that patients at high risk for atypical femoral fracture should consider discontinuing bisphosphonate therapy after five years of continuous use. They also encourage orthopaedists to assess the contralateral femur for signs of impending fracture in patients who have already had an atypical femoral fracture...

   For full story:

   http://www.news-medical.net/news/20150304/New-guidance-to-prevent-bisphosphonate-related-atypical-femoral-fractures.aspx
   

   Return to headline | Return to top

Full Text of Stories Below